209 related articles for article (PubMed ID: 16166323)
1. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
Deguchi A; Xing SW; Shureiqi I; Yang P; Newman RA; Lippman SM; Feinmark SJ; Oehlen B; Weinstein IB
Cancer Res; 2005 Sep; 65(18):8442-7. PubMed ID: 16166323
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
Liu L; Li H; Underwood T; Lloyd M; David M; Sperl G; Pamukcu R; Thompson WJ
J Pharmacol Exp Ther; 2001 Nov; 299(2):583-92. PubMed ID: 11602670
[TBL] [Abstract][Full Text] [Related]
3. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
Cen B; Deguchi A; Weinstein IB
Cancer Res; 2008 Jul; 68(13):5355-62. PubMed ID: 18593937
[TBL] [Abstract][Full Text] [Related]
4. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
[TBL] [Abstract][Full Text] [Related]
5. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells.
Deguchi A; Thompson WJ; Weinstein IB
Cancer Res; 2004 Jun; 64(11):3966-73. PubMed ID: 15173009
[TBL] [Abstract][Full Text] [Related]
7. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
[TBL] [Abstract][Full Text] [Related]
9. Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.
Fallahian F; Karami-Tehrani F; Salami S; Aghaei M
FEBS J; 2011 Sep; 278(18):3360-9. PubMed ID: 21777390
[TBL] [Abstract][Full Text] [Related]
10. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
Zhu B; Vemavarapu L; Thompson WJ; Strada SJ
J Cell Biochem; 2005 Feb; 94(2):336-50. PubMed ID: 15526282
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.
Shureiqi I; Xu X; Chen D; Lotan R; Morris JS; Fischer SM; Lippman SM
Cancer Res; 2001 Jun; 61(12):4879-84. PubMed ID: 11406566
[TBL] [Abstract][Full Text] [Related]
12. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
[TBL] [Abstract][Full Text] [Related]
14. Sulindac and its derivatives: a novel class of anticancer agents.
Haanen C
Curr Opin Investig Drugs; 2001 May; 2(5):677-83. PubMed ID: 11569947
[TBL] [Abstract][Full Text] [Related]
15. A role for cyclic-GMP dependent protein kinase in anoikis.
Hou Y; Wong E; Martin J; Schoenlein PV; Dostmann WR; Browning DD
Cell Signal; 2006 Jun; 18(6):882-8. PubMed ID: 16139477
[TBL] [Abstract][Full Text] [Related]
16. Activation of the small GTPase Rac1 by cGMP-dependent protein kinase.
Hou Y; Ye RD; Browning DD
Cell Signal; 2004 Sep; 16(9):1061-9. PubMed ID: 15212766
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.
Deguchi A; Soh JW; Li H; Pamukcu R; Thompson WJ; Weinstein IB
Mol Cancer Ther; 2002 Aug; 1(10):803-9. PubMed ID: 12492113
[TBL] [Abstract][Full Text] [Related]
18. Exisulind and guanylyl cyclase C induce distinct antineoplastic signaling mechanisms in human colon cancer cells.
Pitari GM; Li T; Baksh RI; Waldman SA
Mol Cancer Ther; 2006 May; 5(5):1190-6. PubMed ID: 16731751
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.
Soh JW; Kazi JU; Li H; Thompson WJ; Weinstein IB
Mol Carcinog; 2008 Jul; 47(7):519-25. PubMed ID: 18163459
[TBL] [Abstract][Full Text] [Related]
20. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1.
Soh JW; Mao Y; Kim MG; Pamukcu R; Li H; Piazza GA; Thompson WJ; Weinstein IB
Clin Cancer Res; 2000 Oct; 6(10):4136-41. PubMed ID: 11051267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]